Ivabradine (INN) /ɪˈvæbrədiːn/ is a novel medication used for the symptomatic management of stable angina pectoris. It is marketed by Servier under the trade names Procoralan (worldwide) Coralan (in Hong Kong Singapore Australia and some other countries) Corlentor (in Armenia Spain Italy and Romania) and Coraxan (in Russia and Serbia). It is also marketed in India under the brand names Ivabid and Bradia.
This page contains content from the copyrighted Wikipedia article "Ivabradine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
